CJC 1295 no DAC half-life is roughly 30 minutes, far shorter than DAC versions. Learn how long it lasts, typical dosing intervals, and key safety facts.
CJC 1295 no DAC has a half-life of roughly 30 minutes in humans. That means about half of the peptide clears from the bloodstream within half an hour, so levels rise quickly and fall quickly after each injection. The short window is the main reason this version is dosed far more often than CJC-1295 with DAC.
What "Half-Life" Actually Measures
Half-life is the time the body needs to clear 50% of a drug or peptide from circulation. A 30-minute half-life does not mean the compound vanishes in 30 minutes. It usually takes about four to five half-lives, or roughly two hours, before nearly all of it has cleared.
CJC 1295 no DAC is also known as Mod GRF(1-29) or tetrasubstituted GRF(1-29). The peptide mimics growth hormone-releasing hormone (GHRH) and binds GHRH receptors in the pituitary gland, triggering a pulse of growth hormone release.
CJC 1295 No DAC Half-Life vs CJC-1295 With DAC
The two forms differ by a single modification. CJC-1295 with DAC carries a drug affinity complex that binds to albumin in the blood, stretching its half-life from minutes to days. When people search for cjc-1295 dac vs no dac, this gap is usually the core question.
| Compound | Approximate half-life | Typical research dosing frequency |
|---|---|---|
| CJC-1295 no DAC (Mod GRF 1-29) | ~30 minutes | 2–3 times daily |
| CJC-1295 with DAC | ~6–8 days | Once or twice weekly |
| Sermorelin | ~10–12 minutes | Once daily, often at night |
| Tesamorelin | ~26–38 minutes | Once daily |
| Ipamorelin | ~2 hours | 1–3 times daily |
The no-DAC version produces a sharp, short growth hormone pulse. The DAC version produces a steady, low-level elevation that lingers for days, which is a very different physiological pattern.
How the Short Half-Life Shapes Dosing Schedules
Most reported protocols using CJC 1295 no DAC call for injections two or three times per day, often timed around sleep and away from meals. Common discussion of cjc-1295 no dac dosage centers on roughly 100 mcg per injection, though published human data on this exact form remains limited.
- Timing: doses are usually spaced several hours apart to mimic natural GH pulses.
- Frequency: two to three injections daily in most self-reported protocols.
- Pairing: it is frequently combined with a GHRP such as ipamorelin to amplify the response.
A 30-minute half-life simply does not support once-weekly dosing. Anyone following a weekly schedule is almost certainly using the DAC version instead.
Stacking With Ipamorelin and Similar Peptides
CJC 1295 no DAC is rarely used alone in research settings. The cjc 1295 no dac and ipamorelin blend is popular because the two peptides act on different receptors, GHRH and ghrelin, and can produce a larger combined growth hormone release than either one alone.
Search interest in cjc-1295 no dac ipamorelin reddit discussions tends to focus on injection timing, side effects, and whether a blended vial behaves the same as two separate ones. Half-life sits at the center of those conversations, because ipamorelin lasts roughly two hours while CJC 1295 no DAC lasts about 30 minutes.
Pre-mixed blends are commonly sold in 10 mg vials. Because the peptide ratio varies by vendor, the amount of each compound per dose is not standardized, and labels are not always accurate.
How It Compares With Tesamorelin and Sermorelin
All three peptides act on the GHRH receptor, but their half-lives and regulatory status differ. In any comparison of tesamorelin vs cjc-1295 no dac, the two look similar on paper: both clear in roughly half an hour, yet only tesamorelin holds an FDA-approved indication.
Sermorelin clears even faster, at about 10 to 12 minutes, which is why a search for sermorelin vs cjc-1295 no dac ipamorelin keeps returning the same theme. All of these peptides are short-acting, and only some have any approved human use.
Safety, Legal Status, and Real Risks
CJC-1295 no DAC is not FDA-approved for human use in the United States. Products sold online are typically labeled "for research use only" and are not guaranteed to be sterile, pure, or accurately dosed.
Reported side effects of GHRH analogs in research settings include injection-site reactions, flushing, headache, and changes in blood sugar regulation. Stimulating growth hormone can also affect insulin sensitivity and cause fluid retention.
Anyone considering these compounds should talk with a licensed healthcare professional first. Blood work, medical history, and current prescriptions all matter, and self-dosing with unregulated peptides carries genuine risk.
Key Takeaways
- CJC 1295 no DAC has a half-life of about 30 minutes in humans.
- CJC-1295 with DAC lasts roughly 6 to 8 days because of its albumin-binding modification.
- A 30-minute half-life supports frequent small doses, not weekly injections.
- CJC-1295 no DAC is not FDA-approved for human use in the United States.
Frequently Asked Questions
How long does CJC 1295 no DAC stay in your system?
The half-life is roughly 30 minutes, and most of the peptide is cleared within about two hours. Growth hormone release triggered by the injection may last somewhat longer, but blood levels of the peptide itself drop quickly after each dose.
Is CJC 1295 no DAC the same as Mod GRF 1-29?
Yes. CJC 1295 no DAC is another name for Mod GRF(1-29), also written as tetrasubstituted GRF(1-29). It is a modified fragment of growth hormone-releasing hormone without the drug affinity complex found in the longer-acting version.
How often is CJC 1295 no DAC injected?
Reported research protocols usually call for two or three injections per day because of the short half-life. CJC-1295 no DAC is not FDA-approved for human use, so any dosing schedule comes from informal reports rather than approved medical guidance.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.